Investment Visual

ASND

Ascendis Pharma A/S

Stock

$227.87+0.56 (+0.25%)Close Oct 2, 2026

Stock-based compensation, 2025: €116M
YoY, 2025: +21.6%
5-year CAGR: +16.9%
10-year CAGR: +52.5%

Stock-based compensation

Stock-based compensation by fiscal year

Period	Ended	Stock comp	YoY	Filing
2025	Dec 31, 2025	€116M	+21.6%	20-F, Feb 11, 2026
2024	Dec 31, 2024	€96M	+43.3%	20-F, Feb 12, 2025
2023	Dec 31, 2023	€67M	+3.9%	20-F, Feb 7, 2024
2022	Dec 31, 2022	€64M	−4.0%	20-F, Feb 16, 2023
2021	Dec 31, 2021	€67M	+25.7%	20-F, Mar 2, 2022
2020	Dec 31, 2020	€53M	+41.8%	20-F, Mar 10, 2021
2019	Dec 31, 2019	€37M	+90.7%	20-F, Apr 3, 2020
2018	Dec 31, 2018	€20M	+102.4%	20-F, Apr 3, 2019
2017	Dec 31, 2017	€9.7M	+32.6%	20-F, Mar 28, 2018
2016	Dec 31, 2016	€7.3M	+327.4%	20-F, Mar 28, 2018
2015	Dec 31, 2015	€1.7M	—	20-F, Mar 28, 2018